首页|美托洛尔联合烟酰胺治疗心力衰竭合并心律失常的效果及对患者心功能的影响

美托洛尔联合烟酰胺治疗心力衰竭合并心律失常的效果及对患者心功能的影响

扫码查看
目的 研究美托洛尔联合烟酰胺治疗心力衰竭(HF)合并心律失常的临床效果及对患者心功能的影响.方法 以2020年11月-2022年11月广丰和祥医院收治的60例HF合并心律失常患者为研究对象,经随机数字表法分为对照组(30例)与观察组(30例).对照组给予美托洛尔治疗,观察组在其基础上联合烟酰胺治疗,比较两组临床疗效、心功能[左室射血分数(LVEF)、左室舒张末期内径(LVEDD)、左室收缩末期内径(LVESD)]、心律失常发作情况(发作频率、持续时间)、Memorial心力衰竭症状评估量表(MSAS-HF)评分及不良反应.结果 观察组总有效率(93.33%)高于对照组(76.67%)(P<0.05).两组治疗后LVEF大于治疗前,LVEDD、LVESD小于治疗前,且观察组LVEF大于对照组,LVEDD、LVESD小于对照组(P<0.05).两组治疗后心律失常发作频率、持续时间少于治疗前,且观察组心律失常发作频率、持续时间少于对照组(P<0.05).两组治疗后MSAS-HF评分低于治疗前,且观察组MSAS-HF评分低于对照组(P<0.05).两组不良反应发生率比较,差异无统计学意义(P>0.05).结论 美托洛尔联合烟酰胺治疗HF合并心律失常效果确切,可改善患者心功能,减少心律失常发作频率和时间,缓解心衰症状,且不增加药物不良反应,安全性良好.
Effect of Metoprolol Combined with Nicotinamide in the Treatment of Heart Failure Complicated with Arrhythmia and its Influence on Cardiac Function
Objective To study the clinical effect of metoprolol combined with nicotinamide in the treatment of heart failure(HF)complicated with arrhythmia and its effect on cardiac function.Methods A total of 60 patients with HF complicated with arrhythmia admitted to Guangfeng Hexiang Hospital from November 2020 to November 2022 were divided into control group(30 patients)and observation group(30 patients)by random number table method.The control group was treated with metoprolol,and the observation group was treated with nicotinamide on the basis of the control group.The clinical efficacy,cardiac function[left ventricular ejection fraction(LVEF),left ventricular end-diastolic diameter(LVEDD),left ventricular end-systolic diameter(LVESD)],arrhythmia attack(frequency and duration of attack),Memorial Symptom Assessment Scale-Heart Failure(MSAS-HF)score and adverse reactions were compared between the two groups.Results The total effective rate of the observation group(93.33%)was higher than that of the control group(76.67%)(P<0.05).After treatment,LVEF in the two groups was higher than that before treatment,LVEDD and LVESD were lower than those before treatment,and LVEF in the observation group was higher than that in the control group,LVEDD and LVESD were lower than those in the control group(P<0.05).After treatment,the frequency and duration of arrhythmia in the two groups were less than those before treatment,and the frequency and duration of arrhythmia in the observation group were less than those in the control group(P<0.05).After treatment,the MSAS-HF score of the two groups was lower than that before treatment,and the MSAS-HF score of the observation group was lower than that of the control group(P<0.05).There was no significant difference in the incidence of adverse reactions between the two groups(P>0.05).Conclusion Metoprolol combined with nicotinamide is effective in the treatment of HF complicated with arrhythmia,which can improve the cardiac function of patients,reduce the frequency and time of arrhythmia,relieve the symptoms of heart failure,and do not increase the adverse drug reactions,with good safety.

Heart failureArrhythmiasMetoprololNicotinamideCardiac function

姜如华

展开 >

广丰和祥医院心血管内科,江西上饶 334699

心力衰竭 心律失常 美托洛尔 烟酰胺 心功能

2024

医学信息
国家卫生部信息化管理领导小组 中国电子学会中国医药信息学分会 陕西文博生物信息工程研究所

医学信息

影响因子:0.161
ISSN:1006-1959
年,卷(期):2024.37(10)
  • 21